Cassava Sciences Inc. (SAVA) touched a new high 2 times within the past 5 days.


Cassava Sciences Inc. (NASDAQ:SAVA) saw a downside of -22.59% to $28.21 after subtracting -$8.23 on Tuesday. The 5-day average trading volume is 2,300,434 shares of the company’s common stock. It has gained $38.53 in the past week and touched a new high 2 times within the past 5 days. An average of 1,493,124 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,451,479.

SAVA’s 1-month performance is -3.42% or -$3.77 on its low of $26.50 reached on 01/03/23. The company’s shares have touched a 52-week low of $13.84 and high of $62.49, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, SAVA has achieved 23.36% or -$1.63 and has reached a new high 4 times. However, the current price is down -54.86% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Valuation Metrics

SAVA stock has a beta of -0.02. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 7.35.

Cassava Sciences Inc.’s quick ratio for the period ended September 29 was 22.10, with the current ratio over the same period at 22.10.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income grew 52.81% to -$20.26 million, while revenue of -$19.33 million was 4.59% off the previous quarter. Analysts expected SAVA to announce -$0.48 per share in earnings in its latest quarter, but it posted -$0.51, representing a -6.30% surprise. SAVA stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 8.57 million, with total debt at $0.16 million. Shareholders hold equity totaling $40.07 million.

Let’s look briefly at Cassava Sciences Inc. (SAVA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 35.69% to suggest the stock is trending Neutral, with historical volatility in this time period at 162.71%.

The stock’s 5-day moving average is $33.28, reflecting a -19.29% or -$6.67 change from its current price. SAVA is currently trading -16.06% above its 20-day SMA, +6.36% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -19.31% and SMA200 by-4.42%.

Stochastic %K and %D was 57.18% and 70.80% and the average true range (ATR) pointed at 3.57. The RSI (14) points at 39.28%, while the 14-day stochastic is at 3.62% with the period’s ATR at 3.39. The stock’s 9-day MACD Oscillator is pointing at -0.79 and 0.75 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Cassava Sciences Inc. (NASDAQ: SAVA), B. Riley Securities downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for SAVA stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate SAVA as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.

What is SAVA’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $44.00 and a high of $124.00, with their median price target at $100.00. Looking at these predictions, the average price target given by analysts is for Cassava Sciences Inc. (SAVA) stock is $89.33.


Please enter your comment!
Please enter your name here